Inovio Pharmaceuticals, Inc.

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Jong Joseph Kim. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Jong Joseph Kim har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:INO / Inovio Pharmaceuticals, Inc. Chief Executive Officer, Director 139.386
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Jong Joseph Kim. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb INO / Inovio Pharmaceuticals, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i INO / Inovio Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2020-01-13 INO Kim Jong Joseph 22.500 3,1100 1.875 37,3200 69.975 168 380.28 643.050 918,97
2014-08-12 INO Kim Jong Joseph 250.000 9,0550 20.833 108,6600 2.263.750
2014-04-15 INO Kim Jong Joseph 25.000 2,2500 2.083 27,0000 56.250
2013-04-02 INO Kim Jong Joseph 90.000 0,5020 7.500 6,0240 45.180
2013-03-20 INO Kim Jong Joseph 60.000 0,5280 5.000 6,3360 31.680
2012-06-13 INO Kim Jong Joseph 15.000 0,4060 1.250 4,8720 6.090
2012-06-05 INO Kim Jong Joseph 25.000 0,4100 2.083 4,9200 10.250
2012-05-10 INO Kim Jong Joseph 50.000 0,4800 4.167 5,7600 24.000
2012-03-22 INO Kim Jong Joseph 19.116 0,6185 1.593 7,4220 11.823
2012-03-21 INO Kim Jong Joseph 30.884 0,6170 2.574 7,4040 19.055

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

INO / Inovio Pharmaceuticals, Inc. Insider Trades
Insidersalg INO / Inovio Pharmaceuticals, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i INO / Inovio Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2019-06-03 INO Kim Jong Joseph 832.848 2,2987 69.404 27,5844 1.914.468 120 23.64 -273.756 -14,30
2019-06-03 INO Kim Jong Joseph 296.705 2,3078 24.725 27,6936 684.736
2019-05-31 INO Kim Jong Joseph 500.000 2,4353 41.667 29,2236 1.217.650
2019-05-31 INO Kim Jong Joseph 500.000 2,4016 41.667 28,8192 1.200.800
2019-05-21 INO Kim Jong Joseph 100.000 3,3100 8.333 39,7200 331.000
2018-09-12 INO Kim Jong Joseph 49.060 5,3700 4.088 64,4400 263.452
2018-04-13 INO Kim Jong Joseph 107.500 5,0550 8.958 60,6600 543.412
2018-04-12 INO Kim Jong Joseph 103.750 5,1387 8.646 61,6644 533.140
2017-03-31 INO Kim Jong Joseph 73.590 6,5739 6.132 78,8868 483.773
2017-03-30 INO Kim Jong Joseph 73.590 6,5051 6.132 78,0612 478.710

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

INO / Inovio Pharmaceuticals, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Jong Joseph Kim som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2022-03-14 2022-03-11 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -139.387 139.386 -50,00
2022-03-14 2022-03-11 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -39.698 1.422.627 -2,71 3,22 -127.828 4.580.859
2022-03-14 2022-03-11 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 139.387 1.462.325 10,54
2022-03-09 2022-03-08 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -63.700 0 -100,00
2022-03-09 2022-03-08 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -18.142 1.322.938 -1,35 3,26 -59.143 4.312.778
2022-03-09 2022-03-08 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 63.700 1.341.080 4,99
2022-03-01 2022-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 468.500 468.500
2022-03-01 2022-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
A - Award 627.700 627.700
2022-03-01 2022-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -68.767 137.533 -33,33
2022-03-01 2022-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -20.045 1.277.380 -1,54 3,22 -64.545 4.113.164
2022-03-01 2022-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 68.767 1.297.425 5,60
2021-03-12 2021-03-11 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -139.387 278.773 -33,33
2021-03-12 2021-03-11 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -74.545 1.228.658 -5,72 10,57 -787.941 12.986.915
2021-03-12 2021-03-11 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 139.387 1.303.203 11,98
2021-03-09 2021-03-08 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -63.700 63.700 -50,00
2021-03-09 2021-03-08 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -34.067 1.163.816 -2,84 8,91 -303.537 10.369.601
2021-03-09 2021-03-08 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 63.700 1.197.883 5,62
2021-03-09 2021-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -120.100 0 -100,00
2021-03-09 2021-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -64.230 1.134.183 -5,36 9,19 -590.274 10.423.142
2021-03-09 2021-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 120.100 1.198.413 11,14
2021-02-26 2021-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 206.300 206.300
2021-02-26 2021-02-26 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
A - Award 319.800 319.800
2021-02-03 2021-02-03 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
M - Exercise -62.500 0 -100,00
2021-02-03 2021-02-03 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -62.500 1.078.313 -5,48 14,24 -890.000 15.355.177
2021-02-03 2021-02-03 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 62.500 1.140.813 5,80 4,56 285.000 5.202.107
2021-02-03 2021-02-01 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -100.000 1.078.313 -8,49 15,00 -1.500.000 16.174.695
2020-12-31 2020-12-29 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
G - Gift -10.000 1.178.313 -0,84
2020-07-31 2020-07-30 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -100.000 1.188.313 -7,76 21,13 -2.113.450 25.114.401
2020-03-12 2020-03-11 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 418.160 418.160
2020-03-12 2020-03-10 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -105.700 0 -100,00
2020-03-12 2020-03-10 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -36.826 1.288.313 -2,78 5,70 -209.908 7.343.384
2020-03-12 2020-03-10 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 105.700 1.325.139 8,67
2020-03-09 2020-03-08 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -63.700 127.400 -33,33
2020-03-09 2020-03-08 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -27.697 1.219.439 -2,22 14,09 -390.251 17.181.896
2020-03-09 2020-03-08 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 63.700 1.247.136 5,38
2020-03-09 2020-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -120.100 120.100 -50,00
2020-03-09 2020-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -37.371 1.183.436 -3,06 9,80 -366.236 11.597.673
2020-03-09 2020-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 120.100 1.220.807 10,91
2020-01-13 2020-01-13 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
P - Purchase 22.500 1.100.707 2,09 3,11 69.975 3.423.199
2019-06-04 2019-06-03 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale -296.705 816.527 -26,65 2,31 -684.736 1.884.381
2019-06-04 2019-06-03 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale -832.848 1.078.207 -43,58 2,30 -1.914.468 2.478.474
2019-06-04 2019-05-31 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale -500.000 1.113.232 -30,99 2,40 -1.200.800 2.673.538
2019-06-04 2019-05-31 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale -500.000 1.911.055 -20,74 2,44 -1.217.650 4.653.992
2019-05-23 2019-05-21 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale -100.000 2.411.055 -3,98 3,31 -331.000 7.980.592
2019-05-17 2019-05-16 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -61.212 1.613.232 -3,66 3,50 -214.242 5.646.312
2019-05-17 2019-05-15 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -75.556 1.674.444 -4,32 3,50 -264.446 5.860.554
2019-03-12 2019-03-10 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -105.700 105.700 -50,00
2019-03-12 2019-03-10 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -30.104 2.511.055 -1,18 3,34 -100.547 8.386.924
2019-03-12 2019-03-10 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 105.700 2.541.159 4,34
2019-03-12 2019-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -57.333 0 -100,00
2019-03-12 2019-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -16.329 2.435.459 -0,67 3,34 -54.539 8.134.433
2019-03-12 2019-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 57.333 2.451.788 2,39
2019-03-12 2019-03-08 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 191.100 191.100
2019-03-12 2019-03-08 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
A - Award 298.100 298.100
2019-03-07 2019-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -120.100 240.200 -33,33
2019-03-07 2019-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -34.139 2.394.455 -1,41 3,61 -123.242 8.643.983
2019-03-07 2019-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 120.100 2.428.594 5,20
2018-09-14 2018-09-12 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
M - Exercise -49.060 0 -100,00
2018-09-14 2018-09-12 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale -49.060 2.308.494 -2,08 5,37 -263.452 12.396.613
2018-09-14 2018-09-12 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 49.060 2.357.554 2,13 5,08 249.225 11.976.374
2018-05-09 2018-05-08 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -23.333 0 -100,00
2018-05-09 2018-05-08 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -6.646 2.308.494 -0,29 4,68 -31.103 10.803.752
2018-05-09 2018-05-08 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 23.333 2.315.140 1,02
2018-04-13 2018-04-13 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
M - Exercise -107.500 0 -100,00
2018-04-13 2018-04-13 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale -107.500 2.291.807 -4,48 5,06 -543.412 11.585.084
2018-04-13 2018-04-13 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 107.500 2.399.307 4,69 2,16 232.200 5.182.503
2018-04-13 2018-04-12 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
M - Exercise -103.750 0 -100,00
2018-04-13 2018-04-12 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale -103.750 2.291.807 -4,33 5,14 -533.140 11.776.909
2018-04-13 2018-04-12 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 103.750 2.395.557 4,53 2,40 249.000 5.749.337
2018-03-13 2018-03-10 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -105.700 211.400 -33,33
2018-03-13 2018-03-10 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -30.104 2.291.807 -1,30 4,51 -135.769 10.336.050
2018-03-13 2018-03-10 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 105.700 2.321.911 4,77
2018-03-13 2018-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -57.334 57.333 -50,00
2018-03-13 2018-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -15.944 2.216.211 -0,71 4,51 -71.907 9.995.112
2018-03-13 2018-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 57.333 2.232.155 2,64
2018-03-07 2018-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 360.300 360.300
2018-03-07 2018-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
A - Award 138.250 138.250
2018-03-07 2018-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -13.333 0 -100,00
2018-03-07 2018-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -3.711 2.174.822 -0,17 4,29 -15.920 9.329.986
2018-03-07 2018-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 13.333 2.178.533 0,62
2017-08-01 2017-07-28 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
M - Exercise -61.325 0 -100,00
2017-08-01 2017-07-28 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 61.325 2.165.200 2,91 5,08 311.531 10.999.216
2017-05-09 2017-05-08 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -23.333 23.333 -50,00
2017-05-09 2017-05-08 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -10.755 2.103.875 -0,51 6,29 -67.649 13.233.374
2017-05-09 2017-05-08 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 23.333 2.114.630 1,12
2017-04-03 2017-03-31 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
M - Exercise -73.590 0 -100,00
2017-04-03 2017-03-31 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale -73.590 2.091.297 -3,40 6,57 -483.773 13.747.977
2017-04-03 2017-03-31 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 73.590 2.164.887 3,52 5,08 373.837 10.997.626
2017-04-03 2017-03-30 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
M - Exercise -73.590 73.590 -50,00
2017-04-03 2017-03-30 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale -73.590 2.091.297 -3,40 6,51 -478.710 13.604.096
2017-04-03 2017-03-30 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 73.590 2.164.887 3,52 5,08 373.837 10.997.626
2017-03-13 2017-03-10 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 317.100 317.100
2017-03-13 2017-03-10 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
A - Award 43.150 43.150 6,68 288.242 288.242
2017-03-13 2017-03-10 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -52.605 2.091.297 -2,45 6,68 -351.401 13.969.864
2017-03-13 2017-03-10 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 139.745 2.143.902 6,97
2017-03-13 2017-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -57.334 114.666 -33,33
2017-03-13 2017-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -17.787 2.004.157 -0,88 6,61 -117.572 13.247.478
2017-03-13 2017-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 57.334 2.021.944 2,92
2017-03-07 2017-03-06 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -4.365 1.964.610 -0,22 6,95 -30.337 13.654.040
2017-03-07 2017-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -13.333 13.333 -50,00
2017-03-07 2017-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 13.333 1.968.975 0,68
2016-06-10 2016-06-08 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
M - Exercise -245.300 0 -100,00
2016-06-10 2016-06-08 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -110.866 1.955.642 -5,36 11,24 -1.246.134 21.981.416
2016-06-10 2016-06-08 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 245.300 2.066.508 13,47 5,08 1.246.124 10.497.861
2016-05-10 2016-05-09 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -9.098 1.821.208 -0,50 9,52 -86.613 17.337.900
2016-05-10 2016-05-08 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -23.334 46.666 -33,33
2016-05-10 2016-05-08 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 23.334 1.830.306 1,29
2016-03-11 2016-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 172.000 172.000
2016-03-11 2016-03-09 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
A - Award 172.000 172.000 7,02 1.207.440 1.207.440
2016-03-08 2016-03-07 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
F - Taxes -4.440 1.806.972 -0,25 7,48 -33.211 13.516.151
2016-03-08 2016-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -13.334 26.666 -33,34
2016-03-08 2016-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 13.334 1.811.412 0,74
2015-08-03 2015-07-31 4 INO INOVIO PHARMACEUTICALS, INC.
Warrant (right to buy)
X - Other -306.625 0 -100,00
2015-08-03 2015-07-31 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
X - Other 306.625 1.798.078 20,56 5,08 1.557.655 9.134.236
2015-05-08 2015-05-08 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
A - Award 40.000 40.000 8,01 320.400 320.400
2015-05-08 2015-05-08 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 70.000 70.000
2015-03-09 2015-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
A - Award 85.000 85.000 7,56 642.600 642.600
2015-03-09 2015-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 40.000 40.000
2014-08-12 2014-08-12 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
P - Purchase 250.000 1.750.000 16,67 9,06 2.263.750 15.846.250
2014-08-12 2014-05-22 4/A INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
A - Award 50.000 50.000 8,80 440.000 440.000
2014-05-23 2014-05-22 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
A - Award 340.000 340.000 2,20 748.000 748.000
2014-04-15 2014-04-15 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
P - Purchase 25.000 5.965.809 0,42 2,25 56.250 13.423.070
2014-03-27 2014-03-26 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
A - Award 300.000 300.000 3,23 969.000 969.000
2013-04-02 2013-04-02 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
P - Purchase 90.000 11.940.809 0,76 0,50 45.180 5.994.286
2013-03-20 2013-03-20 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
P - Purchase 60.000 11.850.809 0,51 0,53 31.680 6.257.227
2013-03-18 2013-03-14 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
A - Award 430.000 430.000 0,54 232.200 232.200
2013-01-08 2013-01-04 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
G - Gift 50.000 134.130 59,43 0,53 26.495 71.075
2013-01-08 2013-01-04 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
G - Gift 50.000 134.130 59,43 0,53 26.495 71.075
2013-01-08 2013-01-04 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
G - Gift 50.000 134.250 59,35 0,53 26.495 71.139
2013-01-08 2013-01-04 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
G - Gift -150.000 11.790.809 -1,26 0,53 -79.485 6.247.950
2012-06-13 2012-06-13 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
P - Purchase 15.000 11.940.809 0,13 0,41 6.090 4.847.968
2012-06-06 2012-06-05 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
P - Purchase 25.000 11.925.809 0,21 0,41 10.250 4.889.582
2012-05-10 2012-05-10 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
P - Purchase 50.000 11.900.809 0,42 0,48 24.000 5.712.388
2012-03-23 2012-03-22 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
P - Purchase 19.116 11.850.809 0,16 0,62 11.823 7.329.725
2012-03-23 2012-03-21 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
P - Purchase 30.884 11.831.693 0,26 0,62 19.055 7.300.155
2012-03-06 2012-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
G - Gift 45.600 84.130 118,35
2012-03-06 2012-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
G - Gift 45.600 84.130 118,35
2012-03-06 2012-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
G - Gift 45.600 84.250 117,98
2012-03-06 2012-03-05 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
G - Gift -136.800 11.800.809 -1,15
2012-02-27 2012-02-23 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
A - Award 415.000 415.000 0,60 249.000 249.000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)